GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hefei Lifeon Pharmaceutical Co 003020.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

15.12

-0.53%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Hefei Lifeon Pharmaceutical Co

Its shares trade on Shenzhen under the ticker 003020.SZ. It has been listed since 15 December 2020. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.55bn and net income of CN¥165.2m. At that date it held total assets of CN¥2.59bn and shareholders' equity of CN¥1.81bn.

Hefei Lifeon Pharmaceutical Co., Ltd. engages in the operation of pharmaceutical industry, and pharmaceutical business. The company is headquartered in Hefei, Anhui. The company went IPO on 2020-12-15. The firm is also engaged in the wholesale and retailing of pharmaceuticals and medical devices. The firm's main products involve cardiovascular drugs, digestive system drugs and skin topical drugs.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
15 Dec 2020
Employees
1,219
Website
lifeon.cn ↗

Leadership

Pay as last reported

  • Mr. Junqu JiChairman of the Board, since 2010CN¥763,800
  • Ms. Xiaojuan DengVice Chairman of the Board, since 2018CN¥766,300
  • Ms. Yi LiuChief Financial Officer
  • Mr. Huanxi CuiGeneral Manager, Director, since 2023
  • Mr. Jun XiaDeputy General Manager, Secretary of tjhe BoardCN¥455,600
  • Mr. Tiecheng JiDeputy General Manager, Director, since 2025
  • Mr. Tianhe DaiDeputy General ManagerCN¥626,500
  • Mr. Shaobing GouDeputy General ManagerCN¥471,000
  • Mr. Yong ZhengDeputy General Manager
  • Ms. Yun FangStaff Elected Director
  • Mr. Jinhua LiIndependent DirectorCN¥24,000
  • Mr. Jing ShiIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Hefei Lifeon Pharmaceutical employs 1,219 full-time staff members in the pharmaceutical industry.
  • The company operates in Hefei, Anhui, focusing on pharmaceutical business operations.
  • Main products include cardiovascular drugs, digestive system drugs, and skin topical drugs.

Weaknesses

  • The firm engages in wholesale and retailing of medical devices alongside pharmaceuticals.
  • Operations are concentrated in the single city of Hefei, Anhui province.
  • The company went public on 15 December 2020, indicating a relatively recent listing.

Opportunities

  • The firm can expand its wholesale and retailing of pharmaceuticals in new markets.
  • Growth potential exists in the cardiovascular drugs segment due to high demand.
  • Expanding the digestive system drugs portfolio could attract more healthcare consumers.

Threats

  • Competition in the pharmaceutical industry may reduce market share for existing products.
  • Regulatory changes in China could impact the wholesale and retailing of medical devices.
  • Economic fluctuations might affect consumer spending on skin topical drugs significantly.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.